• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Lannett CDMO

    Federal Equipment Company

    U.S. Pharmacopeia (USP)

    LOTTE BIOLOGICS

    AMERIPHARMA
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Lannett CDMO

    Federal Equipment Company

    U.S. Pharmacopeia (USP)

    LOTTE BIOLOGICS

    AMERIPHARMA
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Artificial Intelligence and Machine Learning in Healthcare

    Because your summertime reading should make you a little uncomfortable.

    Artificial Intelligence and Machine Learning in Healthcare
    Ben Locwin, PhD, MBA, MS, Contributing Editor07.15.19
    We are now in the future—where artificial intelligence (AI) and machine learning (ML) are components of our overall healthcare strategy for humanity. This was at least the future as far as the past was concerned. Now we see the limitations of AI and ML and it’s our job to enhance both to make how we perceive our current visions of ‘the future’ (according to now) to be the most effective it can be for the identification and mitigation of diseases and disorders.

    Artificial intelligence and machine learning
    These aren’t synonymous terms, so rule #1 is to stop using them both interchangeably as though they are. Artificial intelligence is a broader term within which machine learning resides. Machine learning is a subset in which a computer program can be fed data which it incorporates into its algorithmic structure to make better and better predictions about future problems posed to it.

    AI and machine learning are both best-suited to identify high-data situations that certainly could be solved by humans, but for which that solution or set of solutions would require the review and synthesis of thousands of pages (or more) worth of data, and would be prohibitive for people to actually do. A good current example of the use of AI (really ML) in healthcare is Google’s system to better detect lung cancer. According to the American Cancer Society, lung cancer is the current leading cause of cancer deaths for both men and women. Out of an estimated 228,000 new cases that will be identified this year, there will be an estimated 143,000 deaths. To address this need, machine learning is being trialed to help improve the current, ridiculously-low hit-rate, diagnostic technology better serve patients who may have lung cancer.

    Here’s the background: Lung cancer screening currently involves low-dose CT scanning, and has a 96% false positive rate. On a lung CT scan, about one quarter of images reveal shadowing features which are consistent with nodules in the lung. Of those results, however, fewer than 4% of patients actually have lung cancer. This creates unnecessary anxiety, unneeded further testing—likely more invasively and not risk-free—and a degradation in patient global health status. When putting computation to the test, the machine learning that was used in the study was able to correctly identify every actual positive case of cancer, and in one of the larger tests, the Google machine learning protocol outperformed 6 radiologists reading the same results by identifying 5% more actual cancer cases. At the same time, the algorithm rejected about 11% of the false positives—a previous study published in the journal Thorax found that false positives were reduced by about 30%. This is sparing the patients from undergoing further unnecessary medical procedures, some of which have resulted in death even though the patient actually had no cancer.

    If you take a look at Figure 1 you’ll see that machine learning is nested within artificial intelligence as a subset, and deep learning is itself a subtype of machine learning. If you’ve missed out on the happenings of artificial intelligence over the past thirty or so years, you may have not noticed that ‘deep learning’ was a thing. Deep learning refers to a type of machine learning that occurs across networks, and is one of the reasons that IBM codenamed one of their learning machines ‘Deep Blue,’ which it pitted against world chess grandmaster Garry Kasparov in a series of high-tension chess matches in 1996-1997; the old human-versus-computer showdown writ large. Spoiler alert: IBM’s supercomputer won. On this topic of machines taking over the world at the expense of people, some vocal pundits have taken their opinions of AI and ML to the media to make outrageous claims that AI is going to destroy humanity if we aren’t careful. The reality is far more prosaic and it’s probabilistically very unlikely that it will pose a direct threat to us. It’s unfortunate, but the people who give public opinions about AI or machine learning are spectacularly uninformed.


    Figure 1: Artificial Intelligence, Machine Learning, Deep Learning

    Using AI and ML for pharma applications
    Big data analytics, in silico drug design and molecular modeling, and trial risk prediction—a subset of predictive analytics—are all right within the sweet spot of machine learning for pharmaceutical development and deployment. Previously, I’ve worked on a publication which included risk assessment and in silico development tools (referenced below) and it offered absolute cutting-edge approaches to some of these challenges by some of the most luminary thinkers in different aspects of the field. The future only gets brighter and brighter for these applications, and there is only one thing standing in the way that I see which stands out among all other challenges: Algorithmic opacity.

    Tending to the details of AI and ML (and DL)
    We do need to understand better what some of the algorithms are actually doing, when they start assembling learning strategies on their own. This is what I mean by algorithmic opacity. For example, recent cosmological modeling of computers done with the help of a type of machine learning led to very accurate results of a virtual version of the cosmos in an incredibly short amount of time. When the programmers and researchers tried to reverse-engineer what exactly was the computational path that led to such accurate results (and so quickly), what they quickly found was that they had no idea what the algorithmic process was. Maybe the principle of parsimony was involved in the calculations. Maybe not.

    It can be deviously difficult to ferret-out what the decision-making process was which led an in silico model to return one favorable alternative instead of another. Sometimes impossible. And this is a HUGE extant problem for us. If you haven’t spent a sleepless night over this yet, perhaps plan on not sleeping tonight as you think through the implications. For a highly-regulated industry, not knowing how a decision was reached which used available data is very problematic.

    Also, as these technologies are rolled out to greater and greater effect clinically, not knowing the reason behind particular decisions is very troubling. This requires unwinding certain decisions post hoc and a posteriori; which is philosophically almost bordering on anti-science. Add to this that for the European markets, GDPR requires “meaningful information of the logic involved” when automated decision-making takes place (Articles 13, 14 and 15). Helping patients will be threatened with being hamstrung by political motivations if we can’t reduce the algorithmic opacity. 

    References
    • American Cancer Society. (2019). Lung cancer. https://www.cancer.org/cancer/lung-cancer.html
    • Ardila, D. et al. (2019). End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nature Medicine, 25, 954-961.
    • Zurdo, J. et al. (2015). Developability of Biotherapeutics: Computational Approaches. https://www.crcpress.com/Developability-of-Biotherapeutics-Computational-Approaches/Kumar-Kumar-Singh/p/book/9781482246131 


    Ben Locwin, PhD, MBA, MS

    Ben Locwin is a healthcare futurist and industry executive, having worked in pharmaceuticals, medical devices, and medical technologies to improve the balance of care available to patients. Says Dr. Locwin, “Every single patient that receives medical care is exposed to at least one drug therapy or device as part of the course of diagnosis and treatment. We have the direct opportunity and moral imperative to make these approaches better and safer for the future.”
    Related Searches
    • drug design
    • study
    • it
    • Testing
    Suggested For You
    Re-Open Your Tool Chest Re-Open Your Tool Chest
    Sanofi and Google to Develop Innovation Lab Sanofi and Google to Develop Innovation Lab
    The Future Is… Therapeutic The Future Is… Therapeutic
    The Manufacturing Revolution In Medicine The Manufacturing Revolution In Medicine
    Improving Your Development Program Improving Your Development Program
    CPhI NA Keynotes: Former Senator Jeff Flake & Numerate CTO Brandon Allgood CPhI NA Keynotes: Former Senator Jeff Flake & Numerate CTO Brandon Allgood
    CENTOGENE Appoints AI Director CENTOGENE Appoints AI Director
    Three Key Challenges for Wide-Scale AI Adoption in Pharma Three Key Challenges for Wide-Scale AI Adoption in Pharma
    The Unfolding Pharma Product Mix The Unfolding Pharma Product Mix
    Career Inflection Points Career Inflection Points
    Leveraging Deep Learning in Drug Research Leveraging Deep Learning in Drug Research
    Celgene Enters AI Drug Discovery Deal with Exscientia Celgene Enters AI Drug Discovery Deal with Exscientia
    Synthetic Control Arms Synthetic Control Arms
    2019 Trends & Predictions 2019 Trends & Predictions
    Implementing AI in Drug Discovery Implementing AI in Drug Discovery

    Related Columns

    • Analytical Services | Laboratory Testing
      Re-Open Your Tool Chest

      Re-Open Your Tool Chest

      There’s no longer an excuse NOT to start “PAT-ing” your products
      Emil W. Ciurczak, DoraMaxx Consulting 07.15.19

    • Drug Development | Drug Discovery | Industry News | Laboratory Testing
      Sanofi and Google to Develop Innovation Lab

      Sanofi and Google to Develop Innovation Lab

      Virtual healthcare Innovation Lab aims to radically transform how future medicines and health services are delivered
      06.18.19

    • Biologics, Proteins, Vaccines | Drug Development
      The Future Is… Therapeutic

      The Future Is… Therapeutic

      As cell and gene therapies rise, so too does outsourcing
      Ben Locwin 06.13.19


    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19

    • Drug Development
      Improving Your Development Program

      Improving Your Development Program

      Seven lab science trends driving the future of drug development.
      Jenifer Vija, Liam Moran, Chris Loosbroock and Eric Snyder, Charles River 05.07.19

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 30
    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    MAV Beauty Recruits Former Elizabeth Arden CEO Scott Beattie
    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Happi

    Latest Breaking News From Happi

    Is Dr. Barbara Sturm Skincare Considering a Sale?
    YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
    Christian Siriano Appointed Olay’s First Chief Drop Officer
    Ink World

    Latest Breaking News From Ink World

    MicroDynamics, All Printing Resources Partner to Represent Veritas
    Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
    Siegwerk’s Climate Targets Validated by SBTi
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 30
    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login